PMID- 36629549 OWN - NLM STAT- MEDLINE DCOM- 20230113 LR - 20230113 IS - 1678-4375 (Electronic) IS - 1519-6984 (Linking) VI - 82 DP - 2023 TI - Inflammation reduction potential of nanostructured lipid carriers encapsulated with rat's bone marrow cells' lysate. PG - e269553 LID - S1519-69842022000100781 [pii] LID - 10.1590/1519-6984.269553 [doi] AB - Bone marrow-derived mesenchymal stromal cells (BMSCs) have been used for treating inflammatory disorders. Due to the large size of BMSCs compared to nanoparticles, BMSCs cannot be loaded into the nanoparticles. It is hypothesized that BMSCs lysate loading into the nanocarriers will effectively deliver cellular contents and regulatory elements of BMSCs at the injury site. This study aimed to investigate nanostructured lipid carriers (NLC) loading with BMSCs lysate through basic characterization and morphological analysis. Moreover, this study was mainly designed to investigate the role of NLC loaded BMSCs lysate in reducing inflammation via in-vitro and in-vivoassays. The in-vitro study involves cell viability assays, p53, annexin V and VEGF expression through ELISA and immunocytochemistry, real-time BAX, caspase-3, IL-6, IL-8, TOP2A, PCNA, and Ki-67 gene expression analysis. Additionally, to evaluate in-vivo anti-inflammatory activity, the carrageenan-induced rat paw oedema model was used. In-vitro results showed that NLC loaded BMSCs lysate increased cell viability, decreased apoptosis and pro-inflammatory genes expression and up-regulated angiogenesis and proliferation in H2O2 pre-stimulated cells. Findings of the in-vivo assay also indicated a reduction in rat's paw oedema volume in NLC-loaded BMSCs lysate, and downregulation of BAX, Caspase-3, IL-6, and IL-8 was observed. Enhanced expressions of TOP2A, PCNA, and Ki-67 were obtained. Concluding the results of this study, NLC-loaded BMSCs lysate could reduce inflammation and possibly regenerate damaged tissue mainly via increasing cell viability, angiogenesis and proliferation, and reducing apoptosis and pro-inflammatory cytokines. FAU - Malik, S AU - Malik S AUID- ORCID: 0000-0002-0709-7226 AD - The University of Lahore, Institute of Molecular Biology and Biotechnology - IMBB, Lahore, Pakistan. FAU - Awan, S J AU - Awan SJ AUID- ORCID: 0000-0001-5333-6702 AD - The University of Lahore, Institute of Molecular Biology and Biotechnology - IMBB, Lahore, Pakistan. AD - Kinnaird College For Women, Department of Zoology, Lahore, Pakistan. FAU - Farzand, A AU - Farzand A AUID- ORCID: 0000-0002-0829-6323 AD - The University of Lahore, Institute of Molecular Biology and Biotechnology - IMBB, Lahore, Pakistan. FAU - Ali, Q AU - Ali Q AUID- ORCID: 0000-0002-3160-4830 AD - University of the Punjab, Department of Plant Breeding and Genetics, Lahore, Pakistan. LA - eng PT - Journal Article DEP - 20230106 PL - Brazil TA - Braz J Biol JT - Brazilian journal of biology = Revista brasleira de biologia JID - 101129542 RN - EC 3.4.22.- (Caspase 3) RN - BBX060AN9V (Hydrogen Peroxide) RN - 0 (bcl-2-Associated X Protein) RN - 0 (Proliferating Cell Nuclear Antigen) RN - 0 (Interleukin-6) RN - 0 (Interleukin-8) RN - 0 (Ki-67 Antigen) RN - 0 (Lipids) SB - IM MH - Rats MH - Animals MH - Caspase 3/metabolism/pharmacology MH - *Hydrogen Peroxide/pharmacology MH - bcl-2-Associated X Protein/metabolism/pharmacology MH - Proliferating Cell Nuclear Antigen/metabolism/pharmacology MH - *Interleukin-6/metabolism/pharmacology MH - Interleukin-8/metabolism/pharmacology MH - Ki-67 Antigen/metabolism MH - Inflammation/chemically induced/metabolism MH - Lipids MH - Bone Marrow Cells MH - Edema/metabolism EDAT- 2023/01/12 06:00 MHDA- 2023/01/14 06:00 CRDT- 2023/01/11 10:06 PHST- 2022/11/15 00:00 [received] PHST- 2022/12/01 00:00 [accepted] PHST- 2023/01/11 10:06 [entrez] PHST- 2023/01/12 06:00 [pubmed] PHST- 2023/01/14 06:00 [medline] AID - S1519-69842022000100781 [pii] AID - 10.1590/1519-6984.269553 [doi] PST - epublish SO - Braz J Biol. 2023 Jan 6;82:e269553. doi: 10.1590/1519-6984.269553. eCollection 2023.